Cleared Special

K191465 - Human IgM Kit for use on SPAPlus (FDA 510(k) Clearance)

Jun 2019
Decision
24d
Days
Class 2
Risk

K191465 is an FDA 510(k) clearance for the Human IgM Kit for use on SPAPlus. This device is classified as a Method, Nephelometric, Immunoglobulins (g, A, M) (Class II - Special Controls, product code CFN).

Submitted by The Binding Site Group , Ltd. (Edgbaston, GB). The FDA issued a Cleared decision on June 27, 2019, 24 days after receiving the submission on June 3, 2019.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5510.

Submission Details

510(k) Number K191465 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 03, 2019
Decision Date June 27, 2019
Days to Decision 24 days
Submission Type Special
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code CFN — Method, Nephelometric, Immunoglobulins (g, A, M)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5510